Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1 interacts with a member of the interferon-stimulated gene 15 pathway

Journal of Virology

Volumn 89, Issue 22, 2015, Pages 11572-11583

  Jacobs, Sarah R ^a   Stopford, Charles M ^a   West, John A ^a   Bennett, Christopher L ^a   Giffin, Louise ^a   Damania, Blossom ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1; INTERFERON STIMULATED GENE 15; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CYTOKINE; HERC5 PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR; ISG15 PROTEIN, HUMAN; SIGNAL PEPTIDE; SMALL INTERFERING RNA; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; VIRAL INTERFERON REGULATORY FACTORS; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VIRUS LATENCY; VIRUS REPLICATION; AMINO ACID SEQUENCE; ENZYME ACTIVATION; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; VIRUS ACTIVATION;

AMINO ACID SEQUENCE; CYTOKINES; ENZYME ACTIVATION; HEK293 CELLS; HERPESVIRUS 8, HUMAN; HUMANS; INTERFERON REGULATORY FACTORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 3; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84945895145     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01482-15     Document Type: Article

References (34)

1. Potter JL, Narasimhan J, Mende-Mueller L, Haas AL. 1999. Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitinlike protein. J Biol Chem 274:25061-25068. http://dx.doi.org/10.1074/jbc.274.35.25061.
2. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95:15623-15628. http://dx.doi.org/10.1073/pnas.95.26.15623.
3. Loeb KR, Haas AL. 1992. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 267:7806-7813.
4. Narasimhan J, Potter JL, Haas AL. 1996. Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J Biol Chem 271:324-330. http://dx.doi.org/10.1074/jbc.271.1.324.
5. Hemelaar J, Borodovsky A, Kessler BM, Reverter D, Cook J, Kolli N, Gan-Erdene T, Wilkinson KD, Gill G, Lima CD, Ploegh HL, Ovaa H. 2004. Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins. Mol Cell Biol 24:84-95. http://dx.doi.org/10.1128/MCB.24.1.84-95.2004.
6. Zhang D, Zhang DE. 2011. Interferon-stimulated gene 15 and the protein ISGylation system. J Interferon Cytokine Res 31:119-130. http://dx.doi.org/10.1089/jir.2010.0110.
7. Jeon YJ, Yoo HM, Chung CH. 2010. ISG15 and immune diseases. Biochim Biophys Acta 1802:485-496. http://dx.doi.org/10.1016/j.bbadis.2010.02.006.
8. Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, Zhu LH, Wang C. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 30:2424-2436. http://dx.doi.org/10.1128/MCB.01466-09.
9. Lenschow DJ. 2010. Antiviral properties of ISG15. Viruses 2:2154-2168. http://dx.doi.org/10.3390/v2102154.
10. Zhao C, Collins MN, Hsiang TY, Krug RM. 2013. Interferon-induced ISG15 pathway: an ongoing virus-host battle. Trends Microbiol 21:181-186. http://dx.doi.org/10.1016/j.tim.2013.01.005.
11. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, WolffT, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HWT. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104:1371-1376. http://dx.doi.org/10.1073/pnas.0607038104.
12. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx.doi.org/10.1126/science.7997879.
13. Ablashi DV, Chatlynne LG, Whitman JE, Jr, Cesarman E. 2002. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15:439-464. http://dx.doi.org/10.1128/CMR.15.3.439-464.2002.
14. Schulz TF. 1998. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 79:1573-1591. http://dx.doi.org/10.1099/0022-1317-79-7-1573.
15. Jacobs SR, Damania B. 2011. The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes? Front Immunol 2:19. http://dx.doi.org/10.3389/fimmu.2011.00019.
16. Jacobs SR, Gregory SM, West JA, Wollish AC, Bennett CL, Blackbourn DJ, Heise MT, Damania B. 2013. The viral interferon regulatory factors of Kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by Toll-like receptor 3. J Virol 87:798-806. http://dx.doi.org/10.1128/JVI.01851-12.
17. West J, Damania B. 2008. Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol 82: 5440-5449. http://dx.doi.org/10.1128/JVI.02590-07.
18. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad SciUSA 102:10200-10205. http://dx.doi.org/10.1073/pnas.0504754102.
19. Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. 2006. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 281:4334-4338. http://dx.doi.org/10.1074/jbc. M512830200.
20. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77:4205-4220. http://dx.doi.org/10.1128/JVI.77.7.4205-4220.2003.
21. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174:12-21. http://dx.doi.org/10.1016/j.jviromet.2011.03.012.
22. Durfee LA, Huibregtse JM. 2012. The ISG15 conjugation system. Methods Mol Biol 832:141-149. http://dx.doi.org/10.1007/978-1-61779-474-2_9.
23. Lin P, Hu SW, Chang TH. 2003. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol Sci 71:20-26. http://dx.doi.org/10.1093/toxsci/71.1.20.
24. Burysek L, Yeow WS, Lubyova B, Kellum M, Schafer SL, Huang YQ, Pitha PM. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 73:7334-7342.
25. Lin R, Genin P, Mamane Y, Sgarbanti M, Battistini A, Harrington WJ, Jr, Barber GN, Hiscott J. 2001. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20:800-811. http://dx.doi.org/10.1038/sj.onc.1204163.
26. Zhao C, Hsiang TY, Kuo RL, Krug RM. 2010. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci U S A 107:2253-2258. http://dx.doi.org/10.1073/pnas.0909144107.
27. Zhu FX, Cusano T, Yuan Y. 1999. Identification of the immediateearly transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol 73:5556-5567.
28. Kim MJ, Hwang SY, Imaizumi T, Yoo JY. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 82:1474-1483. http://dx.doi.org/10.1128/JVI.01650-07.
29. Morales DJ, Lenschow DJ. 2013. The antiviral activities of ISG15. J Mol Biol 425:4995-5008. http://dx.doi.org/10.1016/j.jmb.2013.09.041.
30. Sun Z, Li Y, Ransburgh R, Snijder EJ, Fang Y. 2012. Nonstructural protein 2 of porcine reproductive and respiratory syndrome virus inhibits the antiviral function of interferon-stimulated gene 15. J Virol 86:3839-3850. http://dx.doi.org/10.1128/JVI.06466-11.
31. Marcos-Villar L, Lopitz-Otsoa F, Gallego P, Munoz-Fontela C, Gonzalez-Santamaria J, Campagna M, Shou-Jiang G, Rodriguez MS, Rivas C. 2009. Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J Virol 83:8849-8858. http://dx.doi.org/10.1128/JVI.00339-09.
32. Marcos-Villar L, Campagna M, Lopitz-Otsoa F, Gallego P, Gonzalez-Santamaria J, Gonzalez D, Rodriguez MS, Rivas C. 2011. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. J Gen Virol 92:188-194. http://dx.doi.org/10.1099/vir.0.024984-0.
33. Marcos-Villar L, Gallego P, Munoz-Fontela C, de la Cruz-Herrera CF, Campagna M, Gonzalez D, Lopitz-Otsoa F, Rodriguez MS, Rivas C. 2014. Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation. Oncogene 33: 495-503. http://dx.doi.org/10.1038/onc.2012.603.
34. Ma Z, Jacobs SR, West JA, Stopford C, Zhang Z, Davis Z, Barber GN, Glaunsinger BA, Dittmer DP, Damania B. 2015. Modulation of the cGASSTING DNA sensing pathway by gammaherpesviruses. Proc Natl Acad Sci USA112:E4306-15. http://dx.doi.org/10.1073/pnas.1503831112.